Cargando…

Increased CD160 expression on circulating natural killer cells in atherogenesis

BACKGROUND: Atherosclerosis (AS) presents characteristic of a chronic inflammatory disease in which both adaptive and innate immune cells play roles. Accumulating evidence has showed the impairment of natural killer (NK) cells in atherosclerosis, however, the mechanisms of this impairment remain unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Jin, Shan, Zhaoliang, Zhou, Lin, Yu, Jian, Liu, Xiaopeng, Gao, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467674/ https://www.ncbi.nlm.nih.gov/pubmed/26071079 http://dx.doi.org/10.1186/s12967-015-0564-3

Ejemplares similares

Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus
por: Lin, Syh-Jae, et al.
Publicado: (2016)

Exosomes and Atherogenesis
por: Lin, Bingbing, et al.
Publicado: (2021)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Follicular Stimulating Hormone Accelerates Atherogenesis by Increasing Endothelial VCAM-1 Expression
por: Li, Xiaosa, et al.
Publicado: (2017)

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
por: Wang, Guan-Nan, et al.
Publicado: (2017)

Increased level and interferon-γ production of circulating natural killer cells in patients with scrub typhus
por: Kang, Seung-Ji, et al.
Publicado: (2017)

Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974)

Platelets in Inflammation and Atherogenesis
por: Nording, Henry M., et al.
Publicado: (2015)

Roles of Macrophages in Atherogenesis
por: Farahi, Lia, et al.
Publicado: (2021)

Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression
por: Viganò, Selena, et al.
Publicado: (2014)

Notable epigenetic role of hyperhomocysteinemia in atherogenesis
por: Zhou, Shuyu, et al.
Publicado: (2014)

Natural killer cells in obstetric antiphospholipid syndrome
por: Huo, Rongxiu, et al.
Publicado: (2022)

Human CD8(+) T-Cell Populations That Express Natural Killer Receptors
por: Koh, June-Young, et al.
Publicado: (2023)

CD160 isoforms and regulation of CD4 and CD8 T-cell responses
por: El-Far, Mohamed, et al.
Publicado: (2014)

Characterization of Circulating Natural Killer Cells in Neotropical Primates
por: Carville, Angela, et al.
Publicado: (2013)

Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis
por: Kullberg, Susanna, et al.
Publicado: (2021)

CD160 is essential for NK-mediated IFN-γ production
por: Tu, Tony C., et al.
Publicado: (2015)

Correction: Circulating Levels of Human Salusin-β, a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Methotrexate in Atherogenesis and Cholesterol Metabolism
por: Coomes, Eric, et al.
Publicado: (2011)

The Importance of the Plasma Membrane in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2022)

Telomere Length: Implications for Atherogenesis
por: Yin, Hao, et al.
Publicado: (2023)

Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
por: Peng, Yun-Peng, et al.
Publicado: (2016)

Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy
por: Xie, Jiayong, et al.
Publicado: (2021)

The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment
por: Cui, Feng, et al.
Publicado: (2019)

CD160 receptor in CLL: Current state and future avenues
por: Oumeslakht, Loubna, et al.
Publicado: (2022)

BBBBB160 /
por: Kozer, José
Publicado: (2013)

Infectious Agents Are Not Necessary for Murine Atherogenesis
por: Wright, Samuel D., et al.
Publicado: (2000)

The Dynamics of Oxidized LDL during Atherogenesis
por: Itabe, Hiroyuki, et al.
Publicado: (2011)

Intestinal Immunity and Gut Microbiota in Atherogenesis
por: Yamashita, Tomoya
Publicado: (2017)

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
por: Wiciński, Michał, et al.
Publicado: (2020)

Role of Telomeres Shortening in Atherogenesis: An Overview
por: Yegorov, Yegor E., et al.
Publicado: (2021)

Participation of Krüppel-like Factors in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2023)

Hypotheses on Atherogenesis Triggering: Does the Infectious Nature of Atherosclerosis Development Have a Substruction?
por: Lusta, Konstantin A., et al.
Publicado: (2023)

Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver
por: Di Censo, Chiara, et al.
Publicado: (2021)

A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy
por: Cheng, Zih-Fei, et al.
Publicado: (2021)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters Show Stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It
por: Ponomarenko, Mikhail, et al.
Publicado: (2020)

HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage
por: Muscate, Franziska, et al.
Publicado: (2018)

High Levels of CD244 Rather Than CD160 Associate With CD8(+) T-Cell Aging
por: Wang, Xinyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d83sk6u9mv1sqpds8io4omop56